Skip to main content
Premium Trial:

Request an Annual Quote

Heligenics, Jackson Lab Partner to Study Breast Cancer Gene Variants

NEW YORK — Heligenics said on Tuesday that it has partnered with the Jackson Laboratory to investigate mutations in the ERBB2 breast cancer gene.

Under the terms of the deal, Heligenics will apply its GigaAssay, a massively parallelized platform for assaying molecular functions of single cells in culture, to ERBB2 variants. The resulting data will be included in the Jackson Laboratory's JAX Clinical Knowledgebase, a web-based resource for interpreting cancer genomic profiles.

The Las Vegas-based company said that the partnership aims to identify the impact of thousands of poorly understood ERBB2 mutations and how they cause breast and other cancers, as well as retrospectively analyze how gene mutation/functional library data can improve patient outcomes.

"Heligenics' GigaAssay technology has the potential to advance genomic interpretation," Sara Patterson, manager of clinical analytics and curation at the Jackson Lab, said in a statement. "We are excited for the opportunity to provide large scale interpretation of previously unknown genomic variants to our users, with the hope of connecting patients to relevant treatment options that otherwise may not have been identified."

In late 2019, the Jackson Lab began using Microsoft's artificial intelligence technology to curate the Jax Clinical Knowledgebase.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.